Clinical Trial
-
Neuro
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States
Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative NeurostimulationTM vs. optimal medical management DUBLIN, August 29, 2023–(BUSINESS WIRE)–Mainstay Medical…
Read More » -
Spine
Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial
LOUISVILLE, Colo., June 29, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc…
Read More » -
Spine
Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
MINNEAPOLIS, June 15, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low…
Read More » -
Spine
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent…
Read More » -
Biologics
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
Company plans to begin 30-patient trial later this year April 11, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a…
Read More » -
Spine
Dr. Todd Lanman Begins Breakthrough Low Back Total Joint Replacement Clinical Trial in Beverly Hills with 3Spine, Inc.
BEVERLY HILLS, Calif., March 21, 2023 /PRNewswire/ — Todd Lanman, MD and Lanman Spinal Neurosurgery announced completion of the first lumbar total joint replacement procedure…
Read More » -
Spine
3Spine, Inc. Opens Innovative Clinical Trial for Spine Procedure with Pinehurst Surgical Clinic in Pinehurst, North Carolina
PINEHURST, N.C., March 6, 2023 –PRNewswire — Pinehurst Surgical Clinic today announced successful completion of the first series of cases in the BalancedBack…
Read More » -
Spine
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces…
Read More »